AOXG — Aoxing Pharmaceutical Share Price
Last trade - 00:00- $0.61m
- $20.23m
- $32.33m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.03 | ||
| Price to Tang. Book | 0.04 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | 10.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.23% | ||
| Return on Equity | -7.2% | ||
| Operating Margin | 3.21% | ||
Financial Summary
| Year End 30th Jun | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017E | 2018E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 8.13 | 10.83 | 12.74 | 25.48 | 32.33 | n/a | n/a | 37.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -68.63 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Company holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.
Directors
- Zhenjiang Yue CHM (58)
- Guoan Zhang CFO (47)
- Guirong Zhou CEX (63)
- Jun Min DRC (58)
- Yang Li IND (37)
- Guozhu Xu IND (71)
- Yuelin Zhang IND (61)
- Last Annual
- June 30th, 2016
- Last Interim
- March 31st, 2017
- Incorporated
- January 24th, 1996
- Public Since
- May 28th, 2002
- No. of Employees
- 339
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 76,209,195
- Address
- Suite 106-810, 1098 Foster City Blvd., FOSTER CITY, 94404
- Web
- Phone
- +1 6463671747
- Auditors
- BDO China Shu Lun Pan CPAs
Upcoming Events for AOXG
Similar to AOXG
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
As of Today at 19:16 UTC, shares in Aoxing Pharmaceutical are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Aoxing Pharmaceutical last closed at $0.01 and the price had moved by +56.86% over the past 365 days. In terms of relative price strength the Aoxing Pharmaceutical share price has outperformed the S&P500 Index by +46.55% over the past year.
There is no consensus recommendation for this security.
Find out moreAoxing Pharmaceutical does not currently pay a dividend.
Aoxing Pharmaceutical does not currently pay a dividend.
Aoxing Pharmaceutical does not currently pay a dividend.
To buy shares in Aoxing Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Aoxing Pharmaceutical had a market capitalisation of $0.61m.
Here are the trading details for Aoxing Pharmaceutical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: AOXG
Based on an overall assessment of its quality, value and momentum Aoxing Pharmaceutical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aoxing Pharmaceutical. Over the past six months, its share price has underperformed the S&P500 Index by -49.81%.
As of the last closing price of $0.01, shares in Aoxing Pharmaceutical were trading +14.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aoxing Pharmaceutical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aoxing Pharmaceutical's management team is headed by:
- Zhenjiang Yue - CHM
- Guoan Zhang - CFO
- Guirong Zhou - CEX
- Jun Min - DRC
- Yang Li - IND
- Guozhu Xu - IND
- Yuelin Zhang - IND